Nanosecond Pulsed Field Ablation (nsPFA™) Percutaneous Electrode System is the first and only device to utilize nonthermal, natural, and precise Regulated Cell Death as the primary Mechanism of Action. See how our nsPFA technology is designed to support improved care and outcomes across a range of applications: https://lnkd.in/ecqttCuR Indications for Use: The CellFX Percutaneous Electrode System is FDA Cleared for use in the US and intended for ablation of soft tissue in percutaneous, and intraoperative surgical procedures. The CellFX System is also intended for dermatological procedures requiring ablation and resurfacing of the skin. #nsPFA #PulsedFieldAblation
Pulse Biosciences, Inc.
医疗设备制造业
Hayward,CA 9,283 位关注者
Powering the next generation in bioelectric medicine with Nanosecond Pulsed Field Ablation technology.
关于我们
Pulse Biosciences is the inventor and sole proprietor of Nanosecond Pulsed Field Ablation™ (nsPFA™) technology. We are committed to health innovation that has the potential to improve and extend the lives of patients. Our proprietary Nanosecond Pulsed Field Ablation technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent non-cellular tissue. The people at Pulse Biosciences are some of the top experts in pulsed electric field technologies and have a broad range of engineering expertise across multiple medical device domains and will utilize nsPFA™ technology to treat a variety of applications for which an optimal solution remains unfulfilled. We have a deep and broad IP portfolio with over 130 issued patents globally owned and licensed. With this growing patent portfolio surrounding our innovative technology, Pulse Biosciences seeks to aggressively realize the potential of Nanosecond Pulsed Field Ablation technology by building a rich pipeline of transformative commercial applications.
- 网站
-
http://www.pulsebiosciences.com
Pulse Biosciences, Inc.的外部链接
- 所属行业
- 医疗设备制造业
- 规模
- 51-200 人
- 总部
- Hayward,CA
- 类型
- 上市公司
- 创立
- 2016
- 领域
- Immuno-Oncology、Innovation、Atrial Fibrillation、Cardiac Surgery、Cardiology、Biology和Nanosecond Pulsing
地点
Pulse Biosciences, Inc.员工
动态
-
At Pulse Biosciences our goal is simple: to solve the needs of patients, physicians, and healthcare providers with high-quality, high reliability products designed to improve care and extend lives. See how we’re advancing our mission: https://lnkd.in/ecqttCuR #PatientCare #Innovation #MedDevice
-
-
In honor of #InternationalWomensDay we celebrate the incredible women at Pulse Biosciences! Your passion, dedication, and drive inspire us every day. Whether pioneering new breakthroughs, leading with excellence, or accelerating change, your impact is shaping the future of healthcare. We recognize and appreciate your hard work, creativity and commitment, not just today, but every day. Thank you for all that you do to push boundaries and make a difference! #IWD #AccelerateAction #IWD2025 #EmpowerWomen
-
-
Happy #EmployeeAppreciationDay. Behind every breakthrough, every success, and every patient impact is YOU, our incredible Pulse team. Your passion and expertise fuel everything we do, and we couldn’t be more grateful. Together, we’re pushing boundaries, transforming patient care, and shaping the future of healthcare. Thank you for your hard work, creativity and teamwork. You make Pulse extraordinary! #EmployeeAppreciationDay #ThankYou #PulseProud
-
-
Happy #EmployeeAppreciationDay. Behind every breakthrough, every success, and every patient impact is YOU, our incredible Pulse team. Your passion and expertise fuel everything we do, and we couldn’t be more grateful. Together, we’re pushing boundaries, transforming patient care, and shaping the future of healthcare. Thank you for your hard work, creativity and teamwork. You make Pulse extraordinary! #EmployeeAppreciationDay #ThankYou #PulseProud
-
-
Thank you to everyone who joined us at #AFSymposium2025 in Boston! Watch our live case below highlighting the nsPFA 360 Catheter’s ability to rapidly isolate the pulmonary veins with a fast, efficient workflow. We’re grateful to the Na Homolce Hospital team and Dr. Vivek Reddy for their collaboration and expertise on this case. Congratulations to Prof. Petr Neuzil and Drs. Moritoshi Funasako and Jan Petru for a great live case: https://lnkd.in/gKe3H2tr #EPeeps #nsPFA #PulseBiosciences Caution: Exclusively for Clinical Investigations.
-
Last week Pulse Biosciences hosted our first training class “Alpha” at the nsPulse Field Academy in Hayward, CA where the team learned from and collaborated with the experts in Nanosecond Pulse Field Ablation (nsPFA™) technology. The Pulse “Alpha” team is committed to bringing this exciting new technology to the market and offering alternatives to surgical and thermal intervention, working towards a better future for patients, physicians, and healthcare providers.
-
-
Pulse Biosciences is excited to announce the appointment of Jon Skinner as our new Chief Financial Officer! Jon is an accomplished financial leader who brings extensive experience across both growth-stage and publicly traded medtech companies—managing everything from M&A and corporate development to strategic partnerships and sales operations. His proven track record at organizations like Imperative Care, Teleflex, and Copeland uniquely positions him to guide Pulse Biosciences as we continue to advance Nanosecond Pulsed Field Ablation (nsPFA) technology. We’re confident that Jon’s strategic insights and leadership will help us achieve our mission of revolutionizing patient care through innovative technology. Please join us in welcoming Jon to the Pulse team! Link: https://lnkd.in/g2gGr26H
-
Great presentation by Dr. Stefano Spiezia on nanosecond Pulsed Field Ablation (nsPFA™) technology at the North American Society for Interventional Thyroidology 2025 conference. If you have any questions or would like to meet Dr. Spiezia, please come chat with the Pulse team. #nanoPFA #pulsebiosciences #minimallyinvasive #NASIT2025
-
-
Greetings from the Pulse Biosciences team at the North American Society for Interventional Thyroidology 2025 conference. We're here to discuss how our nanosecond Pulsed Field Ablation (nsPFA™) technology is transforming minimally invasive surgery. Stop by to connect with us and learn more. #nanoPFA #pulsebiosciences #minimallyinvasive #NASIT2025
-